A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 117.

标题
A phase Ib study of lenvatinib (LEN) plus nivolumab (NIV) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study 117.
作者
关键词
-
出版物
JOURNAL OF CLINICAL ONCOLOGY
Volume 38, Issue 4_suppl, Pages 513-513
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2020-02-05
DOI
10.1200/jco.2020.38.4_suppl.513

向作者/读者发起求助以获取更多资源

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started